Leave a Message
We will call you back soon!
Your message must be between 20-3,000 characters!
Please check your E-mail!
SUBMIT
The search yielded (3) results
Somatostatin 14,Catalog Number: KS042001,CAS NO.: 38916-34-6 Somatostatin [SST, GHIH (growth hormone-inhibiting hormone) or SRIF (somatotropin release-inhibiting factor)] is a cyclic peptide hormone existing as two isoforms and produced in the pancreas islet, GI tract and the central nervous system. Tetradecapeptide Somatostatin-14 (SRIF-14, the originally identified somatostatin) and the 28-amino acid Somatostatin-28 (SRIF-28) have similar biological activities but differ in
Somatostatin [SST, GHIH (growth hormone-inhibiting hormone) or SRIF (somatotropin release-inhibiting factor)] is a cyclic peptide hormone existing as two isoforms and produced in the pancreas islet, GI tract and the central nervous system. Tetradecapeptide Somatostatin-14 (SRIF-14, the originally identified somatostatin) and the 28-amino acid Somatostatin-28 (SRIF-28) have similar biological activities but differ in their potency. Somatostatins regulate the endocrine system:
The biological activity of peptides is extensive and important, and they can act on the endocrine system, digestive system, cardiovascular system and so on. Although the history of peptides as pharmaceuticals is relatively short, it develops rapidly and has become a hot spot in the market. In the past decades, the number of peptide medications entering the clinical stage has been increasing, such as Semaglutide, Vasopressin, Edotreotide, Thymopentin, etc. With the rapid